Fundraising Fox

Inscripta

Boulder, US · Delaware corporation · 8 known investors

inscripta.com ↗
Biotech

Founders & leadership

MG
Michael GraigeExecutive Officer
JR
John R. StuelpnagelDirector
RM
Ron McGrathExecutive Officer
SK
Sri KosarajuExecutive Officer, Director
RW
Roger WyseDirector
DL
Dianna L. DeVoreExecutive Officer
BR
Bryan RobertsDirector

Investors · 8

Foresite CapitalLarkspur
iGlobe PartnersSingapore · $600K – $6M
KorysHalle · $5.4M
Oak HC/FTStamford
OMX VenturesLincolnshire
Paladin Capital GroupWashington · $100K – $5M
Spruce Capital PartnersSouth San Franciscovia Roger Wyse · board
Vertical Venture PartnersPalo Alto · $500K – $4M

Reported raises · per SEC filings

Form D private placements
▶$1.9MraisedJun 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Justin FerberExecutive Officer
  • John R. StuelpnagelDirector
  • Roger WyseDirector
  • Kristala L. Jones PratherDirector
  • Sri KosarajuExecutive Officer, Director
  • Bryan RobertsDirector
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedJan 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Justin FerberExecutive Officer
  • John R. StuelpnagelDirector
  • Ron McGrathExecutive Officer
  • Kristala L. Jones PratherDirector
  • Sri KosarajuExecutive Officer, Director
  • Roger WyseDirector
  • Bryan RobertsDirector
Offering amount
$4.4M
Amount sold
$4.4M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.8MraisedJan 2023 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron McGrathExecutive Officer
  • Roger WyseDirector
  • Sri KosarajuExecutive Officer, Director
  • Kristala L. Jones PratherDirector
  • Justin FerberExecutive Officer
  • John R. StuelpnagelDirector
  • Bryan RobertsDirector
Offering amount
$27.8M
Amount sold
$27.8M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150MraisedApr 2021 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael GraigeExecutive Officer
  • John R. StuelpnagelDirector
  • Ron McGrathExecutive Officer
  • Sri KosarajuExecutive Officer, Director
  • Roger WyseDirector
  • Dianna L. DeVoreExecutive Officer
  • Bryan RobertsDirector
Offering amount
$150M
Amount sold
$150M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedNov 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dianna L. DeVoreExecutive Officer
  • Sri KosarajuExecutive Officer, Director
  • Ron McGrathExecutive Officer
  • Michael GraigeExecutive Officer
  • Roger WyseDirector
  • John R. StuelpnagelDirector
  • Bryan RobertsDirector
Offering amount
$50M
Amount sold
$50M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.1MraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John R. StuelpnagelDirector
  • Roger WyseDirector
  • Michael GraigeExecutive Officer
  • Ron McGrathExecutive Officer
  • Dianna L. DeVoreExecutive Officer
  • Sri KosarajuExecutive Officer, Director
  • Bryan RobertsDirector
Offering amount
$8.1M
Amount sold
$8.1M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$92.1MraisedDec 2019 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron McGrathExecutive Officer
  • Jason GammackExecutive Officer
  • Kevin D. NessExecutive Officer, Director
  • Michael GraigeExecutive Officer
  • Dianna DeVoreExecutive Officer
  • Tanya LipscombPromoter
  • Bryan RobertsDirector
  • John R. StuelpnagelDirector
  • Roger WyseDirector
  • Andrew D. GarstPromoter
  • Ryan T. GillPromoter
Offering amount
$125M
Amount sold
$92.1M
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedApr 2019 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin D. NessExecutive Officer, Director
  • Dianna DeVoreExecutive Officer
  • Bryan RobertsDirector
  • John R. StuelpnagelDirector
  • Jason GammackExecutive Officer
  • Andrew D. GarstPromoter
  • Ryan T. GillPromoter
  • Tanya LipscombPromoter
  • Michael GraigeExecutive Officer
  • Roger WyseDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jan 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.